APA (7th ed.) Citation

E, D., S, C., M, M., C, S., P, L., V, B., & H, B. (2021). Nonclinical Safety Assessment of FHTR2163, An Antigen-Binding Fragment Against HTRA1 for the Treatment of Geographic Atrophy. Toxicologic pathology, 49(3), 610. https://doi.org/10.1177/0192623320976095

Chicago Style (17th ed.) Citation

E, Dere, Crowell S, Maia M, Schuetz C, Lai P, Bantseev V, and Booler H. "Nonclinical Safety Assessment of FHTR2163, An Antigen-Binding Fragment Against HTRA1 for the Treatment of Geographic Atrophy." Toxicologic Pathology 49, no. 3 (2021): 610. https://doi.org/10.1177/0192623320976095.

MLA (9th ed.) Citation

E, Dere, et al. "Nonclinical Safety Assessment of FHTR2163, An Antigen-Binding Fragment Against HTRA1 for the Treatment of Geographic Atrophy." Toxicologic Pathology, vol. 49, no. 3, 2021, p. 610, https://doi.org/10.1177/0192623320976095.